CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.
Crispr Therapeutics Ag stock last closed at $53.91, up 0.34% from the previous day, and has increased 10.81% in one year. It has overperformed other stocks in the Biotechnology industry by 0.33 percentage points. Crispr Therapeutics Ag stock is currently +43.57% from its 52-week low of $37.55, and -40.82% from its 52-week high of $91.10.
There are currently 80.28M CRSP shares outstanding. The market value of CRSP is $4.33B. In the last 24 hours, 1.35M CRSP shares were traded.
How to Buy Crispr Therapeutics Ag Stock
Wondering how to invest in Crispr Therapeutics Ag stock? Here's how.
Choose where to buy Crispr Therapeutics Ag stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Crispr Therapeutics Ag stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit money your investment account: Pick your payment method and add your details.
Analyze Crispr Therapeutics Ag stock: The Crispr Therapeutics Ag ticker symbol is CRSP. Is Crispr Therapeutics Ag stock a good investment? Should you buy shares of CRSP? How do CRSP's underlying business fundamentals look? Do top analysts think Crispr Therapeutics Ag is a good buy? Why has CRSP's stock price moved recently? (Hint: Our stock market analysis website can help you understand if CRSP is a good stock to buy).
Make your CRSP purchase: Decide if you will purchase CRSP shares at the current market price or use a limit order to buy CRSP stock at a specific price.
Monitor your CRSP investment: Create a watchlist to track your new investment in Crispr Therapeutics Ag stock.
Step 1: Choose where to buy Crispr Therapeutics Ag stock
You need a brokerage account in order to access the NASDAQ market and buy CRSP stock.
A brokerage account is an investment account that enables you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to global financial markets: From Tech to Energy, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've selected the best brokerage, you need to fill out some personal information so you can invest in CRSP today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Crispr Therapeutics Ag stock
After you have figured out the best place to buy Crispr Therapeutics Ag stock, it's important to research their stock before you buy, so you actually comprehend the risk as well as the opportunity.
Crispr Therapeutics Ag shares quick numbers
CRSP Price
$53.91
1w %
-2.07%
1y %
10.81%
5y %
31.42%
P/E
-27.79x
P/B
2.3x
P/S
11.5x
PEG
N/A
Revenue
$371.21M
Earnings
-$153.61M
Fore. Rev. Growth
52.2%
Fore. Earn. Growth
N/A
Market Cap
$4.33B
Next Earnings
May 30, 2024
Next Dividend
N/A
Crispr Therapeutics Ag Due Diligence Checks
WallStreetZen was built to help part-time investors do more accurate fundamental analysis quickly.
There are more short-term assets than long-term liabilities on the CRSP balance sheet.
Total CRSP debt is lower than 5 years ago, relative to shareholder equity.
CRSP has $1.71B in cash and short term investments. This is enough to cover its annual cash burn of $269.85M.
CRSP has cash burn of 269845000. It has enough cash and short-term investments to cover this for at least one year.
There are more short-term assets than short-term liabilities on the CRSP balance sheet.
CRSP has a low debt to equity ratio of 0.18.
Negative Health Checks:
CRSP profit margin has gone up by 542.3 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy Crispr Therapeutics Ag stock, according to Wall Street analysts?
Out of 11 Equities analysts who research CRSP, the consensus analyst rating on CRSP is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent CRSP Analyst Ratings
Jim Birchenough, a top 18% analyst from Wells Fargo maintains CRSP with a hold rating and raises their CRSP price target from $55.00 to $70.00, on Feb 22, 2024.
Gena Wang, a top 33% analyst from Barclays maintains CRSP with a hold rating and raises their CRSP price target from $61.00 to $80.00, on Feb 22, 2024.
Geulah Livshits, a top 6% analyst from Chardan Capital maintains CRSP with a strong buy rating and raises their CRSP price target from $110.00 to $112.00, on Feb 22, 2024.
Joon Lee, a top 6% analyst from Truist Securities maintains CRSP with a strong buy rating and lowers their CRSP price target from $220.00 to $160.00, on Dec 11, 2023.
Tyler Van Buren, a bottom 5% analyst from TD Cowen downgrades CRSP to a sell rating and announces their CRSP price target of $30.00, on Dec 11, 2023.
Last year, CRSP revenue was $371.21M. Over the past 5 year, CRSP's revenue has increased by 160% per year. This was faster than the Biotechnology industry average of 28.56%.
No, Crispr Therapeutics Ag doesn't provide an income stream by paying out dividends.
CRSP Social Trading Data
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your CRSP purchase
You have two main types of orders:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are usually fine for most investors.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at a given price limit, place a limit order.
Press the Open button and your broker will place your order.
If you require more help with buying stocks on eToro, click the how to video below:
How much does it cost to buy one Crispr Therapeutics Ag share?
As of Apr 26, 2024, it costs $53.91 to buy one share of Crispr Therapeutics Ag stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.185 shares of CRSP.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.